N-803/BCG Approval Signals Paradigm Shift in Management of BCG-Unresponsive NMIBC
Karim Chamie, MD, discusses the significance of the FDA approval of N-803 plus BCG in BCG-unresponsive non–muscle invasive bladder cancer.
Source: onclive.com
Karim Chamie News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Karim Chamie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Karim Chamie Today - Breaking & Trending Today
Dr Chamie on the FDA Approval of N-803 Plus BCG for BCG-Unresponsive NMIBC
Karim Chamie, MD, discusses the FDA approval of nogapendekin alfa plus BCG for patients with BCG-unresponsive non–muscle invasive bladder cancer.
Source: onclive.com
UCLA in the News April 23, 2024
Highlights from The Hill, Health, Los Angeles Times and others.
Source: ucla.edu
FDA approves ImmunityBio's bladder cancer treatment
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio’s treatment for a type of bladder cancer.
Source: latimes.com
FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer.
Source: yahoo.com